Bi Asset Management Fondsmaeglerselskab A Tandem Diabetes Care Inc Transaction History

Bi Asset Management Fondsmaeglerselskab A

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$101.89 - $150.09 $859,238 - $1.27 Million	-8,433 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$81.28 - $104.34 $431,515 - $553,941	-5,309 Reduced 38.63%	8,433 $744,000
Q4 2020 Feb 12, 2021	SELL	$86.4 - $121.75 $801,273 - $1.13 Million	-9,274 Reduced 40.29%	13,742 $1.32 Million
Q3 2020 Nov 09, 2020	BUY	$95.43 - $116.09 $500,816 - $609,240	5,248 Added 29.54%	23,016 $2.61 Million
Q2 2020 Aug 05, 2020	BUY	$60.05 - $98.92 $1.07 Million - $1.76 Million	17,768 New	17,768 $1.76 Million
Q1 2020 May 11, 2020	SELL	$47.37 - $90.04 $25,058 - $47,631	-529 Closed	0 $0
Q4 2019 Mar 19, 2020	SELL	$53.13 - $71.19 $7,544 - $10,108	-142 Reduced 21.16%	529 $32,000
Q2 2019 Mar 19, 2020	BUY	$54.41 - $71.7 $36,509 - $48,110	671 New	671 $43,000

359

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.76B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.